SS
VNRX icon

SBI Securities’s VolitionRx Ltd VNRX Stock Holding History

SBI Securities’s Portfolio VNRX Stock Details VNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$254 Buy
188
+108
+135% +$261 ﹤0.01% 3255
2026
Q1 		$323 Buy
80
+74
+1,233% +$353 ﹤0.01% 3053
2025
Q4 		$30 Hold
6
– – ﹤0.01% 3695
2025
Q3 		$79 Buy
6
+1
+20% +$13 ﹤0.01% 3589
2025
Q2 		$81 Buy
+5
New +$55 ﹤0.01% 3601

Other funds holding VNRX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WANY
Wealthspire Advisors (New York) New York $18.2B AUM 21.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return

SBI Securities's VNRX Position: Q2 2026 in Review

SBI Securities increased its VolitionRx Ltd (VNRX) stake by 135% in Q2 2026, buying an estimated $261 and bringing the position to 188 shares worth $254. The position accounts for ﹤0.01% of the portfolio, ranked #3255.

SBI Securities first reported a position in VNRX in Q2 2025 and has held it in 5 quarters since. The position peaked at $323 in Q1 2026. 20 funds tracked by Wall St. Rank hold VNRX as of Q2 2026.

  • SBI Securities held 188 shares of VolitionRx Ltd worth $254 as of Q2 2026.
  • SBI Securities bought 108 VolitionRx Ltd shares in Q2 2026, an estimated $261.
  • VolitionRx Ltd made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3255 holding.
  • SBI Securities first reported a position in VolitionRx Ltd in Q2 2025 and has held it in 5 quarters since.
  • SBI Securities's VolitionRx Ltd position peaked at $323 in Q1 2026.
  • 20 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.